Jasper Therapeutics, Inc.·4

Oct 13, 6:57 PM ET

MARTELL RON 4

4 · Jasper Therapeutics, Inc. · Filed Oct 13, 2023

Insider Transaction Report

Form 4
Period: 2023-10-12
MARTELL RON
DirectorPresident, CEO and Director
Transactions
  • Tax Payment

    Voting Common Stock

    2023-10-12$0.85/sh87,531$74,401331,188 total
Footnotes (1)
  • [F1]These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares of the Issuer's common stock upon the vesting of restricted stock units.

Documents

1 file
  • 4
    ownership.xmlPrimary